Ci Private Wealth, LLC Immunity Bio, Inc. Transaction History
Ci Private Wealth, LLC
- $63.6 Billion
- Q1 2024
A detailed history of Ci Private Wealth, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 221,530 shares of IBRX stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
221,530
Previous 223,430
0.85%
Holding current value
$1.28 Million
Previous $1.12 Million
6.07%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IBRX
# of Institutions
194Shares Held
67.2MCall Options Held
2.27MPut Options Held
3.23M-
State Street Corp Boston, MA14.2MShares$82.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$78.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$60.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.48MShares$20.2 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.55MShares$8.97 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.32B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...